NL-OMON37702
Not yet recruiting
Phase 2
Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for the Treatment of Metastatic Breast Cancer to the Liver: a pilot study - Chemoembolization with Doxorubicin for Metastatic Breast Cancer .
Antoni van Leeuwenhoek Ziekenhuis0 sites10 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- liver metastases breast cancer
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 10
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with biopsy proven liver dominant ( over 50% volume) metastasis of breast carcinoma
Exclusion Criteria
- •1: significant extrahepatic disease representing an eminent life\-threatening outcome
- •2: more than 75% of hepatic parenchymal involvement
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
DEBDOX for liver metastases in breast carcinomaEUCTR2012-000973-22-NL
Recruiting
Not Applicable
TRENDY trialPatients diagnosed with HCC, Child-Pugh grade A, one tumor 𕟮cm, and 󖾆 years old.NL-OMON28819Erasmus MCDepartment of Radiotherapy100
Recruiting
Phase 2
Transarterial Chemoembolization with Drug-Eluting Beads (standard arm) versus Stereotactic Body Radiation Therapy (experimental arm) for hepatocellular carcinoma: A multicenter randomized phase II trial *The TRENDY trial*NL-OMON44103Erasmus MC, Universitair Medisch Centrum Rotterdam64
Completed
Not Applicable
The Impact of Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma: A Single Center ExperienceHepatocellular carcinomaBCLC stage CHepatocellular carcinomaBCLC stage CTACETransarterial ChemoembolizationTCTR20150221001Rajavithi Hospital44
Completed
Phase 2
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24